Summary
60 / 100 · Bulios Score
What speaks for it
- Out of every 100 USD of revenue, 33 USD is left as net profit.
- Revenue grew by 150% a year over the last 3 years.
- The share price is below the Bulios Fair Price.
What to watch
- It passes only 3 of the 9 points of the Piotroski financial health test.
- For every 100 USD of shareholders' equity it carries 940 USD of debt.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks cheapBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 6.6 USD for 1 USD of yearly profit. Over the last five years it was 8.3 USD on average.
Valuation in detailIs it growing?
Yes, fastRevenue (USD)
Diluted EPS (USD)
- Analyst estimate
Revenue grew by 81% a year over 5 years. Over the last 3 years it grew by 150% a year.
Growth in detailDoes it make money?
Very wellWhere 100 USD of revenue goes
- Cost of sales 16 USD
- Sales and administration 7.5 USD
- Taxes and other 43 USD
- Net profit 33 USD
Net profit, industry median (REIT - Mortgage) 20 USD
Out of every 100 USD of revenue, 33 USD is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenOver the last 12 months it spent more cash than it brought in. Its debt is larger than its cash.
Financial health in detailDoes it pay a dividend?
High, at risk- Yield
- 13.73%
- Paid out of profit
- 91%
You receive $1.56 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 9
- Hold 4
- Sell 0
Today's price within the analysts' price targets
The average target of $13.5 is 19% above today's price. 69% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.